Over 150 top researchers, industry experts, and emerging talent in glycomics recently gathered in Edmonton, Alberta to discuss advancements and the latest trends in glycomics.
Empowering scientists to drive One Health innovation globally
GlycoNet and its Integrated Services advance glycomics research and innovation towards new solutions.
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Five glycomics projects have been awarded funding to develop new tools, diagnostics and therapeutics to improve health for Canadians.
Cutting-edge research goes beyond skin deep
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
PlantForm and UBC researcher receive GlycoNet funds to develop novel treatment for Type-2 diabetes
PlantForm Corporation has teamed up with a University of British Columbia research group led by Dr. Joerg Bohlmann to develop a novel plant-based treatment option for Type-2 diabetes and obesity, with support from GlycoNet.
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
The secret to healthy aging
It’s all about monitoring sugar – but not in the way you may think
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
English 
French